Tag : gravis

Neurology

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Newsemia
The terminal complement inhibitor eculizumab was shown to improve myasthenia gravis-related symptoms in the 26-week, phase 3, randomized, double-blind, placebo-controlled REGAIN study (NCT01997229). In this...
Gastroenterology

Paraneoplastic pemphigus and myasthenia gravis as the first manifestations of a rare case of pancreatic follicular dendritic cell sarcoma: CT findings and review of literature

Newsemia
Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that originates from follicular dendritic cells in lymphoid tissue while paraneoplastic pemphigus (PNP) is an autoimmune...
Neurology

Response to “regarding the article ‘Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis’”

Newsemia
We thank Dr. Panahi immensely for the insightful correspondence regarding our publication. We thoroughly enjoyed learning about the statistical methodology. Source link...
Neurology

Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis.

Newsemia
Related Articles Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis. J Neurol Sci. 2019 Feb 04;399:15-21 Authors: Sabre L, Evoli A,...
Neurology

Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life–threatening continuum of neuromuscular and cardiac toxicity

Newsemia
Immune-checkpoint inhibitors (ICIs) represent a novel therapeutic approach for numerous tumors. However, checkpoint blockade may be complicated by a unique spectrum of immune-related adverse events...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy